Is Lipoprotein(a) a Risk Factor for Blood Clots? Gregory Piazza and Team Publish Landmark Study
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on LinkedIn:
”Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease, including heart attack. Testing for lipoprotein(a) is even a recommendation in some guidelines to identify patients at risk for early heart disease. But is lipoprotein(a) a risk factor for venous thrombosis as well? A recent publication from my group explores the links between lipoprotein(a) and blood clots.”
Read the full article here.
Title: Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Authors: Mariana B Pfeferman, Sina Rashedi, Gregory Y H Lip, Christian Weber, Michelle L O’Donoghue, Steven Nissen, Stephen J Nicholls, Pradeep Natarajan, Jorge Plutzky, Peter Libby, Samuel Z Goldhaber, Gregory Piazza, Behnood Bikdeli
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 17:20Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID
-
Dec 16, 2025, 17:14Piotr Czempik Honored for His Work on Cost Reduction in Blood Transfusions
-
Dec 16, 2025, 17:06Davood KHoda Amorzideh on VTE and Bleeding in Cancer
-
Dec 16, 2025, 16:56Kathryn Mikkelsen on The Beat: Vasculearn Network’s Newsletter for Clot Survivors
-
Dec 16, 2025, 16:50Raul Santos on Sex-Specific Biology and Plasma Fructose Levels in Cardiovascular Risk
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story